CARM carismatx.com: Forvard P/S multiplikatori
Carisma Therapeutics (CARM) bioxavfli chiqindilarni yo'q qilishga oid ekologik standartlarga rioya qiladi. GURU.Markets platformasidagi forward P/S tarixi ushbu jarayonlarni aks ettiradi, bunda 0.60 ko'rsatkichi metrikaning holatini ifodalaydi. Ushbu tendentsiya o'smalarga qarshi kurashish uchun CAR-makrofag platformasining noyobligi bilan bog'liq, garchi yuqori ishlab chiqarish xarajatlari va sug'urta to'lovlari atrofidagi noaniqliklar emitent uchun sezilarli moliyaviy xatarlarni yuzaga keltirsa-da.
Carisma Therapeutics kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- qarzdorlik darajasi va moliyaviy likvidlik ma'lumotlari:
Umumiy qarzning kapitalga nisbati Carisma Therapeutics|CARM - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati carismatx.com|CARM - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Carisma Therapeutics Inc|CARM - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Carisma Therapeutics|Tezkor likvidlik ko‘rsatkichi carismatx.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
CARM - Yakuniy foyda|Kelajakdagi foyda Carisma Therapeutics|CARM - Bozor narxining sof foydaga nisbati|Forvard P/E multiplikatori Carisma Therapeutics|CARM - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|EV/EBITDA multiplikatori CARM|CARM - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Carisma Therapeutics|CARM - Sirpanuvchi yil uchun bir aksiya uchun foyda|Choraklik EPS foyda o'sishi carismatx.com|CARM - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Carisma Therapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning har tomonlama tahlili:CARM (Carisma Therapeutics Inc.)
Carisma Therapeutics (CARM) rivojlanishi ichki ishlab chiqish sikllariga va innovatsion dori vositalarining tijoratlashtirilishiga tayanadi, bu esa makroiqtisodiy omillarga bog'liqlikni minimallashtiradi. Kompaniyaning kutilayotgan P/S koeffitsiyenti tahlili bozor talabi va prognoz qilingan daromadlar o'rtasidagi muvozanatni baholash imkonini beradi hamda hajmdan qat'i nazar, narx tendentsiyasining ishonchliligini belgilaydi; ushbu ko'rsatkichdagi yuqori tebranishlar baholashning spekulyativ tabiatidan va qisqa muddatli narx korreksiyasi xavflarining ortganidan dalolat beradi.
Carisma Therapeutics (CARM) raqobatchilari
Forvard P/S multiplikatori ARGX (argenx.com)|BioNTech Group (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABIVAX - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|Protagonist (PTGX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Immunovant Inc|Narxning prognoz qilingan daromadga nisbati Kiniksa Pharmaceuticals|Grifols Group (GRFS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|Narxning prognoz qilingan daromadga nisbati CLDX (Celldex Therapeutics)|Narxning prognoz qilingan daromadga nisbati Aurinia Pharma AUPH|Sotuvga nisbatan forvard narx BCRX|VERA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx DNTH (Dianthus Therapeutics)|Pharvaris N.V. (PHVS) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati AbCellera Biologics (ABCL)|TRML (Tourmaline Bio Inc) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati PGEN (Intrexon)|Forvard narx/daromad multiplikatori PHAR (Pharming)|NKTR (Nektar) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori UPB (upstreambio.com)|ZBIO (Zenas Biopharma Inc) - Kelajakdagi narxning daromadga nisbati|IMNM - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Gossamer Bio Inc GOSS|KALV: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Septerna Pharma|PVLA (Pieris Corp) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati SVRA|Forvard P/S multiplikatori RIGL|Forvard narx/daromad multiplikatori AnaptysBio Corp ANAB|Astria Therapeutics Inc - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati enGene Holdings Inc. (ENGN)|RAPT Therapeutics Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aerovate Therapeutics, Inc.|ACRS (Aclaris Therapeutics) - Forvard narx/daromad multiplikatori|KYTX: Narxning kutilayotgan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Tiziana Life Sciences|Cabaletta Bio, Inc (CABA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori VTYX (Ventyx Biosciences)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati theratech.com|Forvard P/S multiplikatori AVTX (Avalo Therapeutics, Inc.)|Forvard P/S multiplikatori Eledon Pharmaceuticals Inc. ELDN|AGEN: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx CLYM (Climb Bio, Inc)|ZURA: Forvard P/S multiplikatori|aTyr Pharma, Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Adagene Inc.|IMA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori STTK|Forvard narx/daromad multiplikatori Equillium Bio EQ|Narxning prognoz qilingan daromadga nisbati Connect Biopharma CNTB|IMUX - Forvard narx/daromad multiplikatori|ATRA - Narxning prognoz qilingan daromadga nisbati|InflaRx NV (IFRX) - Forvard narx/daromad multiplikatori|XFOR (X4 Pharmaceuticals Inc.) - Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Adicet Bio Inc. (ACET)|Narxning prognoz qilingan daromadga nisbati celularity.com|Forvard narx/daromad multiplikatori inmunebio.com (INMB)|Narxning prognoz qilingan daromadga nisbati Barinthus Biotherapeutics PLC (BRNS)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Kezar Life Sciences Inc.|SAB Biotherapeutics, Inc - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Akari Therapeutics, Plc (AKTX)|ENLV: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx QTTB (q32bio.com)|GeoVax Labs Inc (GOVX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Edesa|Narxning prognoz qilingan daromadga nisbati iBio, Inc.|XTLB: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati aptevotherapeutics.com APVO|AIM - Forvard narx/daromad multiplikatori|Aditxt - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati GRI Bio Corporation GRI|xortx.com (XRTX) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati reshapelifesciences.com (HIND)|Narxning prognoz qilingan daromadga nisbati Revelation Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Indaptus Therapeutics, Inc. INDP|Narxning prognoz qilingan daromadga nisbati BiondVax Pharmaceuticals (SCNI)|Forvard narx/daromad multiplikatori CalciMedica CALI|Narxning prognoz qilingan daromadga nisbati Affimed AFMD|ALLK - Forvard narx/daromad multiplikatori|HOOKIPA Pharma, Inc. - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx IGMS (igmbio.com)|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Ocean Biomedical Corp (OCEA) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Forvard P/S multiplikatori thirdharmonicbio.com
